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Different clinical appearances such asYellow nail syndrome and Lichen planus or lichenoid
reactions can originate from close or identical etiologies. They may result from dental
restorativematerials or metal allergy. Interestingly, the nail sometimes returns to its normal
condition, months after the withdrawal of the offending agents.
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INTRODUCTION
Yellow nail syndrome (YNS) is characterized by nail changes,
respiratory disorders, and lymphedema (1). The yellow nails are
unsightly, discolored and hard, show transverse over-curvature,
and are slow growing. Paronychia and onycholysis may be
observed. Nail abnormalities may be the only pattern of this
syndrome.
The diagnosis of lichen planus of the nails (NLP) may be read-
ily made when it exists together with typical cutaneous or mucous
membrane disease. However, in those cases (about 10%) in which
the nail is involved, a definitive diagnosis must be rendered prior
to instituting therapy. NLP alone is rare (1–2%) and presents a
difficult diagnostic challenge. The clinical signs of NLP are depen-
dent on the anatomic site of the nail unit that is involved in
the process. Matrix disease may vary from small atrophic foci to
extensive destruction of the entire fabric of the nail. When the
former change affects the proximal matrix, longitudinal grooves
alternating with normal nail plate areas appear clinically as ony-
chorrhexis. Should the entire length of the matrix be involved in
the same process, actual splits occur. When diffuse atrophy of the
matrix occurs and becomes functionally shorter, a thinner nail
plate results. The change is usually permanent. Severe destruction
of the matrix with subsequent scar formation gives rise to the spe-
cific clinical sign of lichen planus known as pterygium. Taking into
account the risk of permanent dystrophy, nail biopsy is mandatory
before any treatment.
Lichen planus of the nails may have features in common with
that of the skin. These include hyperkeratosis, hypergranulosis,
irregular epidermal hyperplasia, necrotic keratinocytes (Civatte
bodies, hyaline bodies), vacuolar alteration, dense lichenoid
lymphohistiocytic infiltrate with melanophages in the upper
dermis that obscure the dermoepidermal interface, and coarse
collagen bundles in a thickened papillary dermis.
The purpose of this paper is to demonstrate that common eti-
ologies may be responsible for diseases at first glance far from
being close such as YNS and NLP.
Berglund and Carlmark (2) examined nail clippings from
patients with one or more features of YNS. “Their nails were ana-
lyzed by energy dispersive X-ray fluorescence: titanium (Ti) was
regularly found in fingernails in patients but not in control sub-
jects. Visible nail changes were present in only half of the patients.
The diagnosis of YNS remains strictly clinical. Nail changes are
the most common presentation (89%) followed by lymphedema
(80%) and pleural effusion (63%). Only 30% of all cases have pre-
sented with the classical triad (3). The dominant source of Ti ons
was Ti implants in the teeth or elsewhere. The Ti ions were released
through the galvanic action of dental gold or amalgam or through
the oxidative action of fluorides. Stopping the galvanic release of
Ti ions or canceling exposure to Ti dioxide led to recovery. In one
patient with a Ti implant, the symptoms recurred after renewed
exposure to Ti.”
Four men and four women had symptoms of YNS after expo-
sure to Ti dioxide in drug tablets or confectionary (chewing
gum). In fact, the dominant cause of yellow nails in this arti-
cle was the galvanic interaction between gold in the teeth and Ti
implants.
Several publications mention the exposure to drugs (that actu-
ally contain Ti dioxide) preceding the development of yellow nails
and also the return to normal conditions months after withdrawal
of the drugs (4–6).
www.frontiersin.org December 2014 | Volume 1 | Article 46 | 1
MINI REVIEWS IN MEDICINE
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Baran Yellow nail syndrome
Fluorides ions are the only aggressive ions which provide a
protective oxide layer for Ti and Ti alloys. Since hygiene prod-
ucts like tooth pastes and prophylactic gels contain fluorides ions,
Reclaru and Meyer (7) have evaluated the effect of fluoride ions on
Ti and dental alloys used, for example dental implants (a surgical
component that interfaces with the bone of the jaw or skull to sup-
port a dental prosthesis) and superstructures (portion of a dental
implant).“In confined areas where fluoride ions are present, Ti and
the dental alloys tested undergo a corrosive process in the crevices
and pits as soon as the pH drops below 3.5,” which is observed in
any case of dental infection such as lesions of endodontic origin.
Although metal allergy has been considered to be one of the
precipitating factors in LP, there are only few reports that have
shown a clinical association between metal allergy and NLP. In
the study of Nishizawa et al. (8), “the prevalence of positive metal
patch test (PT) results were higher in NLP as compared with oral
lichen planus (OLP). In addition, 60% of these NLP patients (6
of 10 cases) showed clinical improvement after either removal of
the dental materials or systemic disodium cromoglycate therapy.
Positive Patch testing (PT) to metals, such as Cr, Ni and Au, done
in patients were detected in both the dental fillings/braces and in
the nail lesions in some of the authors’s NLP patients. These data
suggest that metals released from dental materials contributed to
the development of NLP via systemic absorption and subsequent
deposition in the nail tissues.”
Kato et al. (9) have reported on a patient with lichen planus of
the buccal mucosa (OLP), the nails, and the skin were caused by
mercury allergy. “Since 1998, a 61-year-old man had felt stinging
on his buccal mucosa when he ate or brushed his teeth and all of
his nails became rough and thin in June 2000. All the lesions biop-
sied showed a dense band-like lymphocytic infiltrate in the upper
dermis and liquefactive degeneration of the basal layer. Patch
testing (PT) showed positive reactions to the toothpaste that he
used sodium N -lauroyl sarcosinate 0.5% aq, mercury 0.05% pet,
ammoniated mercuric chloride 1.0% pet, and thimerosal 0.1%
pet. Mercury was used as a component of his dental fillings. When
these were replaced by the hard resin jacket crowns, the mucosal,
and nail symptoms gradually improved.”
A similar case of allergy due to mercury amalgam has been pre-
sented by Higashi (10) where a patient developed a systemic LP
associated with NLP restricted to the toes.
Yokoseki et al. (11) examined “a 51-year-old man with 20-nail
dystrophy produced by lichen planus, which was histologically
confirmed by a longitudinal biopsy which included the nail matrix.
All the nails had rough surfaces and were atrophied distally and
the proximal nail folds were reddish and swollen. The patient com-
plained of severe itching in these regions.” The authors carried out
patch-tests, which revealed positive reactions to both nickel and
gold. An electromicroanalysis revealed that gold but no nickel had
been used as a component of the dental fillings. After these fill-
ings were replaced by hard resin, jacket crowns, the nail symptoms
dramatically improved.
Takeuchi et al. (12) have observed the case of a 57-year-old man
who had deformities of all 10 fingernails for 18 months before
presentation and deformities of all 10 toenails, for the previous
6 months. The surface of the nails was rough, with excessive lon-
gitudinal ridging. The base of the nails was slightly hypertrophic,
but their tip was atrophic. “All proximal nail folds were reddish
and swollen. The patient complained of severe itching of the
region of the fingernails and fingernail folds. A longitudinal nail
biopsy including the nail matrix revealed the typical histology of
lichen planus. There were also reticular-shaped, milky-white mac-
ules, and erythemas with pigmentations on both buccal mucous
membranes (11). Histological analysis showed lichen planus inter-
mingled with eosinophils. Immunological blood analysis revealed
elevated CD4+ T cells and CD4/CD8 ratio. The patient worked
as a tinsmith for over 30 years and had had dental metal on sev-
eral teeth for approximately 20 years. The metal serie patch test
revealed positive reactions to chromate and tin. Treatment with
systemic steroids was quite effective in treating the nail lesions.”
COMMENTARY
Dental restorative substances are not the only ones responsible for
either YNS or NLP.
Boone et al.’s (13) case report of “a 27-year-old woman who
sought medical advice for purple papular confluent lesions of the
soles and the lateral border of both feet, which appeared isolated.
They had started 4 years previously and were associated with dys-
trophic nails, which were more prominent on the toes than on the
fingers. The patient was also complaining about painful oral and
genital erosions with some synechia in the latter area. A biopsy con-
firmed the clinical diagnosis of lichen planus. The biological exam-
ination results (not specified) were normal. Ciclosporine A was
prescribed and after 1 month, there was a dramatic improvement.
As the patient had been working for 4 years in the photographic
industry (Canon and Agfa Gevaert), PT was performed. In the
photographic chemical serie, it revealed a positive lichenoid reac-
tion after 72 h to metol (4-methyl aminophenol) and phenidone
(1-phenyl-3pyrazolidinone) and, in the metal ions serie, reactions
to gold sodium thiosulfate. Careful consideration was given to the
workplace survey of the patient and showed that all day long she
had contact with metol, phenidone, and gold sodium thiosulfate.
After 6 months treatment, the patient, completely cured, stopped
ciclosporine.” Consequently, it is tempting to consider that color-
film developers might have exhibited a lichen planus induced by
contact to the mentioned agents.
It seems also logical to establish a connection between hydrox-
ylamine, both as a sensitizer and as an irritant to Boone et al.’s
observation (13). Hydroxylamine may produce onycholysis and/or
paronychia (14, 15). Moreover, it has been widely used in color
photograph processing, the chemical industry (oximes synthesis),
the pharmaceutical industry (bactericide, fungicide,antialgal), and
in the manufacture of rubber and plastic compounds, cosmetics,
and soap.
More unusual are the three cases of Sodhi et al. (16)“who devel-
oped a contact dermatitis of periorbital skin and NLP following
the use of topical brimonidine (0.2% twice a day) for primary
open angle glaucoma. These side-effects slowly disappeared on
discontinuing the drug but reappeared on reintroducing topical
formulation.”
DISCUSSION
Different remarks deserve some consideration. Chemically
induced LP has been described with amalgam such as Hg, products
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containing thiol or releasing SH (D-penicillamine that may also
induce YNS in addition to captopril, gold sodium thiomalate) and
external exposure to a chemical agent, which was not a drug such
as color-film development materials.
Some authorities have tried to separate lichenoid reactions from
true lichen planus. Unfortunately, it is usually impossible to dis-
tinguish these conditions with certainty, even histologically and
we should accept that there is a wide etiologic range that has to be
recognized. Although metal allergy has been considered to be one
of the precipitating factors in LP, there are only few reports that
have shown a clinical association between metal allergy and NLP.
Many workers in color-film development have presented with
lichen planus or lichenoid reactions (17–22) but unexpectedly only
one case was associated with“nail dystrophy”affecting all the digits
(13).
Finally, the enigmatic yellow discoloration observed in some
cases of isolated NLP (23–26) may well be considered as a clinical
bridge between LP and YNS. However, above all, we have tried to
demonstrate that a common culprit may be a link for these quite
different diseases.
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